Abstract:NGS-based genetic testing in the diagnosis of rare diseases holds great promise to serve as a first-tier genetic testing tool in the near future.Advancement of NGS technologies provides many options for diagnosing rare disorders associated with different types of genetic variants. Factors must be balanced in a ‘fit-for-purpose’ implementation.The accuracy and reproducibility of NGS should be evaluated in a clinical setting to deliver reliable genetic testing results in different clinical stages of rare diseases.Artificial intelligence (AI) will play a central role in integrating diverse diagnosis information toward an enhanced diagnosis power for rare diseases. Next-generation sequencing (NGS) technologies have changed the landscape of genetic testing in rare diseases. However, the rapid evolution of NGS technologies has outpaced its clinical adoption. Here, we re-evaluate the critical steps in the clinical application of NGS-based genetic testing from an informatics perspective. We suggest a ‘fit-for-purpose’ triage of current NGS technologies. We also point out potential shortcomings in the clinical management of genetic variants and offer ideas for potential improvement. We specifically emphasize the importance of ensuring the accuracy and reproducibility of NGS-based genetic testing in the context of rare disease diagnosis. We highlight the role of artificial intelligence (AI) in enhancing understanding and prioritization of variance in the clinical setting and propose deep learning frameworks for further investigation. Next-generation sequencing (NGS) technologies have changed the landscape of genetic testing in rare diseases. However, the rapid evolution of NGS technologies has outpaced its clinical adoption. Here, we re-evaluate the critical steps in the clinical application of NGS-based genetic testing from an informatics perspective. We suggest a ‘fit-for-purpose’ triage of current NGS technologies. We also point out potential shortcomings in the clinical management of genetic variants and offer ideas for potential improvement. We specifically emphasize the importance of ensuring the accuracy and reproducibility of NGS-based genetic testing in the context of rare disease diagnosis. We highlight the role of artificial intelligence (AI) in enhancing understanding and prioritization of variance in the clinical setting and propose deep learning frameworks for further investigation.

Progress in the diagnosis and treatment of rare diseases in the era of genomic medicine

Rare and undiagnosed diseases: From disease-causing gene identification to mechanism elucidation

Rare disease genomics and precision medicine

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?

An Overview of Advances in Rare Cancer Diagnosis and Treatment

Towards Efficiency in Rare Disease Research: What is Distinctive and Important?

Leaving no patient behind! Expert recommendation in the use of innovative technologies for diagnosing rare diseases

Rare Diseases: Drug Discovery and Informatics Resource

The Role of Precision Medicine in Rare Diseases

The expanding diagnostic toolbox for rare genetic diseases

Next-Generation Therapeutics for Rare Genetic Disorders

Diagnosis, Treatment, and Research Status of Rare Diseases Related to Birth Defects

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Next-generation sequencing and bioinformatics in rare movement disorders

Gene therapy strategies for rare monogenic disorders with nuclear or mitochondrial gene mutations

Rare diseases: human genome research is coming home

Advances in Personalized Diagnosis and Treatment of Treatable Genetic Diseases of Pediatric Neurology in Precision Medicine Period

Dual rare genetic diseases in five pediatric patients: insights from next-generation diagnostic methods

Rare diseases, spotlighting amyotrophic lateral sclerosis, Huntington’s disease, and myasthenia gravis: Insights from landscape analysis of current research

Innovative Measures To Combat Rare Diseases In China: The National Rare Diseases Registry System, Larger-Scale Clinical Cohort Studies, And Studies In Combination With Precision Medicine Research